FDA inspection
Jabil Switzerland Manufacturing GmbH: FDA inspection ending May 5, 2023
FDA inspection 1207778 · No Action Indicated (NAI) · Le Locle
Key facts
| Inspection ID | 1207778 |
|---|---|
| Firm | Jabil Switzerland Manufacturing GmbH |
| FEI number | 3015831087 |
| Address | Chemin Blanc 36/38 |
| City | Le Locle |
| Country | Switzerland |
| Fiscal year | 2023 |
| Inspection end date | May 5, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data